Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994
Peripheral Neuropathy in HIV Infected Patients with the Diffuse Infiltrative Lymphocytosis Syndrome
Ann Neurol 41:438-445, Moulignier,A.,et al, 1997
Acute Diffuse Leukoencephalitis HIV-1 Infection
JNNP 57:105-107, Luer,W.,et al, 1994
Human Immunodeficiency Virus Type 1 Infection and Myopathy:Clinical Relevance of Zidovudine Therapy
Ann Neurol 34:206-211, Grau,J.M.,et al, 1993
Myopathies Assoc with HIV and Zidovudine:Can Their Effects be Distinguished?
Neurol 43:971-976, Simpson,D.M.,et al, 1993
Acquired Immunodeficiency Syndrome, CSF Before & During Long-Term Oral Zidovudine Therapy
Arch Neurol 48:695-699, Tartaglione,T.A.,et al, 1991
Prognosis in AZT Myopathy
Neurol 41:1181-1184, Chalmers,A.C.,et al, 1991
Myopathy in Human Immunodeficiency Virus-Infected Children Receiving Long-Term Zidovudine Therapy
J Pediatr 119:152-155, Walter,E.B.,et al, 1991
Zidovudine Myopathy:A Distinctive Disorder Associated with Mitochondrial Dysfunction
Ann Neurol 29:606-614, Mhiri,C.,et al, 1991
Myopathy with Human Immunodeficiency Virus Type I (HIV-1) Infection:HIV-1 or Zidovudine?
Ann Int Med 113:492-493, Till,M.&MacDonell,K., 1990
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
Zidovudine-Associated Myopathy
Am J Med 86:814-818, Gertner,E.,et al, 1989